Hydrocodone
Allay, Anexsia, Azdone, Bancap, Co-gesic, Codamine, Duradyne Dhc, Flowtuss, Hy-phen, Hycodan, Hycofenix, Hysingla, Lorcet-hd, Lortab, Norcet, Norco, Obredon, Reprexain, Rezira, Tycolet, Vicodin, Vicoprin, Vicoprofen, Vituz, Xtrelus, Zutripro, Zydone, Zyfrel (hydrocodone) is a small molecule pharmaceutical. Hydrocodone was first approved as Vicodin on 1982-01-01. It is used to treat cough, obstructive lung diseases, and postoperative pain in the USA. The pharmaceutical is active against mu-type opioid receptor. In addition, it is known to target kappa-type opioid receptor.
Download report
Favorite
Top Prescription Drugs
Commercial
Trade Name
FDA
EMA
Hysingla (generic drugs available since 1983-03-03, discontinued: Vantrela, Zohydro)
CombinationsHycodan (generic drugs available since 1983-03-03, discontinued: Allay, Anexsia, Azdone, Bancap, Co-gesic, Codamine, Duradyne dhc, Flowtuss, Hy-phen, Hycofenix, Hydropane, Lorcet-hd, Lortab, Norcet, Norco, Obredon, Reprexain, Rezira, Tussigon, Tycolet, Vicodin, Vicoprin, Vicoprofen, Vituz, Xtrelus, Zutripro, Zydone, Zyfrel)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Chlorpheniramine maleate
+
Hydrocodone bitartrate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VITUZ | Persion Pharmaceuticals | N-204307 DISCN | 2013-02-20 | 1 products, RLD |
Hide discontinued
Chlorpheniramine maleate
+
Hydrocodone bitartrate
+
Pseudoephedrine hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ZUTRIPRO | Persion Pharmaceuticals | N-022439 DISCN | 2011-06-08 | 1 products, RLD |
Hide discontinued
Guaifenesin
+
Hydrocodone bitartrate
Guaifenesin
+
Hydrocodone bitartrate
+
Pseudoephedrine hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
HYCOFENIX | Chartwell Pharmaceuticals | N-022279 DISCN | 2015-05-14 | 1 products, RLD |
Hide discontinued
Homatropine methylbromide
+
Hydrocodone bitartrate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
HYCODAN | Genus Lifesciences | N-005213 RX | 1988-07-26 | 2 products, RLD |
Hydrocodone bitartrate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
HYSINGLA ER | Purdue Pharma | N-206627 RX | 2014-11-20 | 7 products, RLD |
Show 2 discontinued
Hydrocodone bitartrate
+
Ibuprofen
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VICOPROFEN | AbbVie | N-020716 DISCN | 1997-09-23 | 1 products, RLD |
Hide discontinued
Hydrocodone bitartrate
+
Pseudoephedrine hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
REZIRA | Persion Pharmaceuticals | N-022442 DISCN | 2011-06-08 | 1 products, RLD |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
hycodan | New Drug Application | 2021-12-29 |
hydrocodone bitartrate and acetaminophen | ANDA | 2023-06-12 |
hysingla er | New Drug Application | 2021-03-01 |
lortab | ANDA | 2022-01-28 |
norco | ANDA | 2023-03-20 |
obredon | New Drug Application | 2021-09-30 |
reprexain | ANDA | 2009-10-27 |
vicoprofen | New Drug Application | 2011-08-12 |
zohydro | New Drug Application | 2015-02-25 |
zydone | ANDA | 2010-07-13 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
cough | HP_0012735 | D003371 | R05 |
obstructive lung diseases | HP_0006536 | D008173 | — |
postoperative pain | — | D010149 | G89.18 |
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Guaifenesin / Hydrocodone Bitartrate, Obredon, Sovereign Pharms | |||
9549907 | 2035-11-13 | DS, DP | U-2023 |
9808431 | 2035-11-13 | DS, DP | U-2023 |
10105324 | 2035-11-13 | DS, DP | U-2023 |
Hydrocodone Bitartrate, Zohydro Er, Recro Gainesville | |||
9132096 | 2034-09-12 | DP | |
9452163 | 2034-09-12 | U-55 | |
9486451 | 2034-09-12 | U-55 | |
9713611 | 2034-09-12 | DP | U-55 |
10092559 | 2034-09-12 | U-55 | |
9265760 | 2033-07-25 | U-1810 | |
9326982 | 2033-07-25 | U-1810 | |
9333201 | 2033-07-25 | U-1810 | |
9339499 | 2033-07-25 | U-1810 | |
9421200 | 2033-07-25 | U-1810 | |
9433619 | 2033-07-25 | U-1810 | |
9610286 | 2033-07-25 | U-1810 | |
10028946 | 2033-07-25 | U-1810 | |
10322120 | 2033-07-25 | DP | |
10456393 | 2033-07-25 | U-1810 | |
10722511 | 2033-07-25 | U-1810 | |
Hydrocodone Bitartrate, Hysingla Er, Purdue Pharma Lp | |||
8808740 | 2031-12-21 | DP | U-1556 |
9572779 | 2031-12-21 | DP | |
9750703 | 2031-12-21 | DP | |
9861584 | 2031-12-21 | DP | |
9872837 | 2031-12-21 | DP | |
9084816 | 2027-08-24 | DP | |
9095614 | 2027-08-24 | U-1556 | |
9095615 | 2027-08-24 | DP | |
9486412 | 2027-08-24 | DP | |
9486413 | 2027-08-24 | DP | |
9492389 | 2027-08-24 | DP | |
9492390 | 2027-08-24 | U-1556 | |
9492391 | 2027-08-24 | U-1556 | |
9545380 | 2027-08-24 | U-1556 | |
9763933 | 2027-08-24 | DP | |
9770416 | 2027-08-24 | DP | |
9775809 | 2027-08-24 | DP | |
11304908 | 2027-08-24 | DP | |
11304909 | 2027-08-24 | U-1556 | |
8309060 | 2023-11-20 | DP | U-1556 |
10130591 | 2023-11-20 | DP | U-1819 |
9675610 | 2023-06-16 | DP | |
10369109 | 2023-06-16 | DP | |
Hydrocodone Bitartrate, Vantrela Er, Teva Branded Pharm | |||
8445018 | 2029-07-31 | DP | |
9216176 | 2027-09-13 | DP | |
9572803 | 2027-09-13 | DP |
HCPCS
No data
Clinical
Clinical Trials
129 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pain | D010146 | EFO_0003843 | R52 | 4 | 7 | 6 | 6 | 2 | 25 |
Postoperative pain | D010149 | G89.18 | 2 | 2 | 6 | 9 | 2 | 21 | |
Chronic pain | D059350 | HP_0012532 | — | — | 3 | 2 | — | 5 | |
Acute pain | D059787 | R52 | 2 | — | — | 1 | 1 | 4 | |
Nausea | D009325 | HP_0002018 | R11.0 | — | — | 2 | 1 | — | 3 |
Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | — | — | 1 | 1 | 2 | |
Rotator cuff injuries | D000070636 | M75.1 | — | 1 | — | 1 | — | 2 | |
Pain management | D059408 | — | — | — | 2 | — | 2 | ||
Constipation | D003248 | HP_0002019 | K59.0 | — | — | — | 2 | — | 2 |
Toothache | D014098 | K08.89 | — | — | — | 1 | 1 | 2 |
Show 29 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Low back pain | D017116 | HP_0003419 | M54.5 | — | 1 | 4 | — | 1 | 6 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | 1 | 1 | — | — | 2 |
Anterior cruciate ligament injuries | D000070598 | — | 1 | 2 | — | — | 2 | ||
Shoulder pain | D020069 | HP_0030834 | M25.51 | — | — | 1 | — | 1 | 2 |
Head and neck neoplasms | D006258 | 1 | — | 1 | — | — | 2 | ||
Vomiting | D014839 | HP_0002013 | R11.1 | — | — | 2 | — | — | 2 |
Postoperative complications | D011183 | — | — | 1 | — | — | 1 | ||
Tibial meniscus injuries | D000070600 | — | — | 1 | — | — | 1 | ||
Multiple myeloma | D009101 | C90.0 | — | — | 1 | — | — | 1 | |
Lymphoma | D008223 | C85.9 | — | — | 1 | — | — | 1 |
Show 8 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Musculoskeletal pain | D059352 | 1 | 1 | — | — | — | 2 | ||
Corneal injuries | D065306 | HP_0000559 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | 7 | — | — | — | — | 7 | ||
Drug interactions | D004347 | 1 | — | — | — | 1 | 2 | ||
Opioid-related disorders | D009293 | EFO_0005611 | F11 | 2 | — | — | — | — | 2 |
Intervertebral disc degeneration | D055959 | HP_0008419 | 1 | — | — | — | — | 1 | |
Spondylolisthesis | D013168 | EFO_0007493 | M43.1 | 1 | — | — | — | — | 1 |
Ankle fractures | D064386 | S82.5 | 1 | — | — | — | — | 1 | |
Stomatitis | D013280 | EFO_1001904 | K12.1 | 1 | — | — | — | — | 1 |
Substance-related disorders | D019966 | EFO_0003890 | F13 | 1 | — | — | — | — | 1 |
Hepatic insufficiency | D048550 | 1 | — | — | — | — | 1 | ||
Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hip fractures | D006620 | EFO_0003964 | S72.00 | — | — | — | — | 1 | 1 |
Anesthesia | D000758 | — | — | — | — | 1 | 1 | ||
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | — | — | 1 | 1 |
Thyroidectomy | D013965 | — | — | — | — | 1 | 1 | ||
Soft tissue injuries | D017695 | — | — | — | — | 1 | 1 | ||
Lacerations | D022125 | — | — | — | — | 1 | 1 | ||
Methods | D008722 | — | — | — | — | 1 | 1 | ||
Tooth migration | D014085 | — | — | — | — | 1 | 1 | ||
Dysmenorrhea | D004412 | HP_0100607 | N94.6 | — | — | — | — | 1 | 1 |
Sleep | D012890 | GO_0030431 | — | — | — | — | 1 | 1 |
Show 2 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | HYDROCODONE |
INN | hydrocodone |
Description | Hydrocodone is a morphinane-like compound that is a semi-synthetic opioid synthesized from codeine. It has a role as a mu-opioid receptor agonist, an opioid analgesic and an antitussive. It is an organic heteropentacyclic compound and a morphinane-like compound. It derives from a hydride of a morphinan. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314 |
Identifiers
PDB | — |
CAS-ID | 125-29-1 |
RxCUI | 5489 |
ChEMBL ID | CHEMBL1457 |
ChEBI ID | 5779 |
PubChem CID | 5284569 |
DrugBank | DB00956 |
UNII ID | 6YKS4Y3WQ7 (ChemIDplus, GSRS) |
Target
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 15,805 documents
View more details
Safety
Black-box Warning
Black-box warning for: Hycodan, Hydrocodone bitartrate and acetaminophen, Hysingla er, Lortab, Norco, Obredon, Zohydro
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
83,315 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more